![1445751-40-5 | 4-Acetoxy-N-ethyl-N-methyltryptamine | 3-[2-(Ethylmethylamino)ethyl]-1H-Indol-4-ol 4-Acetate; 4-AcO-MET ; | C15H20N2O2 | TRC 1445751-40-5 | 4-Acetoxy-N-ethyl-N-methyltryptamine | 3-[2-(Ethylmethylamino)ethyl]-1H-Indol-4-ol 4-Acetate; 4-AcO-MET ; | C15H20N2O2 | TRC](https://www.trc-canada.com/prod-img/A190280.png)
1445751-40-5 | 4-Acetoxy-N-ethyl-N-methyltryptamine | 3-[2-(Ethylmethylamino)ethyl]-1H-Indol-4-ol 4-Acetate; 4-AcO-MET ; | C15H20N2O2 | TRC
![Identification of a MET-eIF4G1 translational regulation axis that controls HIF-1α levels under hypoxia | Oncogene Identification of a MET-eIF4G1 translational regulation axis that controls HIF-1α levels under hypoxia | Oncogene](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41388-018-0256-6/MediaObjects/41388_2018_256_Fig1_HTML.jpg)
Identification of a MET-eIF4G1 translational regulation axis that controls HIF-1α levels under hypoxia | Oncogene
![Discovery of Pyrrolopyridine−Pyridone Based Inhibitors of Met Kinase: Synthesis, X-ray Crystallographic Analysis, and Biological Activities | Journal of Medicinal Chemistry Discovery of Pyrrolopyridine−Pyridone Based Inhibitors of Met Kinase: Synthesis, X-ray Crystallographic Analysis, and Biological Activities | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm800476q/asset/images/large/jm-2008-00476q_0002.jpeg)
Discovery of Pyrrolopyridine−Pyridone Based Inhibitors of Met Kinase: Synthesis, X-ray Crystallographic Analysis, and Biological Activities | Journal of Medicinal Chemistry
![IUCr) Psilacetin derivatives: fumarate salts of the methyl–ethyl, methyl–allyl and diallyl variants of the psilocin prodrug IUCr) Psilacetin derivatives: fumarate salts of the methyl–ethyl, methyl–allyl and diallyl variants of the psilocin prodrug](https://journals.iucr.org/e/issues/2021/02/00/hb7959/hb7959largethumb.jpg)
IUCr) Psilacetin derivatives: fumarate salts of the methyl–ethyl, methyl–allyl and diallyl variants of the psilocin prodrug
![Metabolomics reveals tepotinib‐related mitochondrial dysfunction in MET‐activating mutations‐driven models - Poliaková - 2019 - The FEBS Journal - Wiley Online Library Metabolomics reveals tepotinib‐related mitochondrial dysfunction in MET‐activating mutations‐driven models - Poliaková - 2019 - The FEBS Journal - Wiley Online Library](https://febs.onlinelibrary.wiley.com/cms/asset/af2c7c34-c622-497f-80b5-49a37bc88e6a/febs14852-toc-0001-m.jpg?trick=1682284723408)
Metabolomics reveals tepotinib‐related mitochondrial dysfunction in MET‐activating mutations‐driven models - Poliaková - 2019 - The FEBS Journal - Wiley Online Library
![Fumarate suppresses B-cell activation and function through direct inactivation of LYN | Nature Chemical Biology Fumarate suppresses B-cell activation and function through direct inactivation of LYN | Nature Chemical Biology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41589-022-01052-0/MediaObjects/41589_2022_1052_Figa_HTML.png)
Fumarate suppresses B-cell activation and function through direct inactivation of LYN | Nature Chemical Biology
![Frontiers | Advances in Drugs Targeting Lymphangiogenesis for Preventing Tumor Progression and Metastasis Frontiers | Advances in Drugs Targeting Lymphangiogenesis for Preventing Tumor Progression and Metastasis](https://www.frontiersin.org/files/Articles/783309/fonc-11-783309-HTML-r1/image_m/fonc-11-783309-g001.jpg)
Frontiers | Advances in Drugs Targeting Lymphangiogenesis for Preventing Tumor Progression and Metastasis
![TRIBUTE study shows superiority of Chiesi's Trimbow® (Beclometasone dipropionate (BDP), Formoterol fumarate (FF) and Glycopyrronium bromide (GB)) over Ultibro® in reducing COPD exacerbations1 TRIBUTE study shows superiority of Chiesi's Trimbow® (Beclometasone dipropionate (BDP), Formoterol fumarate (FF) and Glycopyrronium bromide (GB)) over Ultibro® in reducing COPD exacerbations1](https://www.chiesi.es/img/news/SWcPhgGFELLogo.jpg)
TRIBUTE study shows superiority of Chiesi's Trimbow® (Beclometasone dipropionate (BDP), Formoterol fumarate (FF) and Glycopyrronium bromide (GB)) over Ultibro® in reducing COPD exacerbations1
![Metformin improves the therapeutic efficacy of low-dose albendazole against experimental alveolar echinococcosis | Parasitology | Cambridge Core Metformin improves the therapeutic efficacy of low-dose albendazole against experimental alveolar echinococcosis | Parasitology | Cambridge Core](https://static.cambridge.org/content/id/urn%3Acambridge.org%3Aid%3Aarticle%3AS0031182021001633/resource/name/S0031182021001633_figAb.png?pub-status=live)
Metformin improves the therapeutic efficacy of low-dose albendazole against experimental alveolar echinococcosis | Parasitology | Cambridge Core
![Bone and ocular safety of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a 52-week randomized study | Respiratory Research | Full Text Bone and ocular safety of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a 52-week randomized study | Respiratory Research | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12931-019-1126-7/MediaObjects/12931_2019_1126_Fig1_HTML.png)
Bone and ocular safety of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a 52-week randomized study | Respiratory Research | Full Text
![Safety and efficacy of stopping tenofovir disoproxil fumarate in patients with chronic hepatitis B following at least 8 years of therapy: a prespecified follow-up analysis of two randomised trials - The Lancet Safety and efficacy of stopping tenofovir disoproxil fumarate in patients with chronic hepatitis B following at least 8 years of therapy: a prespecified follow-up analysis of two randomised trials - The Lancet](https://www.thelancet.com/cms/attachment/2fe24897-261c-47cb-b424-05d46d590495/gr1.gif)
Safety and efficacy of stopping tenofovir disoproxil fumarate in patients with chronic hepatitis B following at least 8 years of therapy: a prespecified follow-up analysis of two randomised trials - The Lancet
![Metabolic rewiring in the promotion of cancer metastasis: mechanisms and therapeutic implications | Oncogene Metabolic rewiring in the promotion of cancer metastasis: mechanisms and therapeutic implications | Oncogene](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41388-020-01432-7/MediaObjects/41388_2020_1432_Fig1_HTML.png)
Metabolic rewiring in the promotion of cancer metastasis: mechanisms and therapeutic implications | Oncogene
![Frontiers | Physiological Perspectives on the Use of Triheptanoin as Anaplerotic Therapy for Long Chain Fatty Acid Oxidation Disorders Frontiers | Physiological Perspectives on the Use of Triheptanoin as Anaplerotic Therapy for Long Chain Fatty Acid Oxidation Disorders](https://www.frontiersin.org/files/Articles/598760/fgene-11-598760-HTML-r1/image_m/fgene-11-598760-g001.jpg)
Frontiers | Physiological Perspectives on the Use of Triheptanoin as Anaplerotic Therapy for Long Chain Fatty Acid Oxidation Disorders
![Antioxidants | Free Full-Text | Selenomethionine (Se-Met) Induces the Cystine/Glutamate Exchanger SLC7A11 in Cultured Human Retinal Pigment Epithelial (RPE) Cells: Implications for Antioxidant Therapy in Aging Retina Antioxidants | Free Full-Text | Selenomethionine (Se-Met) Induces the Cystine/Glutamate Exchanger SLC7A11 in Cultured Human Retinal Pigment Epithelial (RPE) Cells: Implications for Antioxidant Therapy in Aging Retina](https://www.mdpi.com/antioxidants/antioxidants-10-00009/article_deploy/html/images/antioxidants-10-00009-g001.png)